Form 8-K - Current report:
SEC Accession No. 0000950170-25-058863
Filing Date
2025-04-25
Accepted
2025-04-25 17:15:10
Documents
11
Period of Report
2025-04-21
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-20250421.htm   iXBRL 8-K 62800
  Complete submission text file 0000950170-25-058863.txt   191211

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20250421.xsd EX-101.SCH 31970
13 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20250421_htm.xml XML 4901
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 25875207
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)